Clinical Trial Update: An Exosomal miRNA-based Liquid Biopsy for ICC Detection

View source ↗

Summary

The clinical trial NCT07225452 investigating an exosomal miRNA-based liquid biopsy for detecting intrahepatic cholangiocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Snippet

Sponsor: City of Hope Medical Center | Conditions: Intrahepatic Cholangiocarcinoma (Icc) | Status: COMPLETED